Learn More
Medchemexpress LLC Mindeudesivir hydrobromide | 2779498-79-0 | 98.2% | C24H31DBrN5O7 | 25 MG

Supplier: Medchemexpress LLC 25MGHY145119AS
Mindeudesivir hydrobromide (VV116) is a deuterated version of Remdesivir, a highly orally active nucleoside antiviral agent against SARS-CoV-2 and respiratory syncytial virus (RSV). It maintains the antiviral activity of Remdesivir against COVID-19 and is noted as the first domestically produced deuterium targeting COVID-19. Deuteration can affect the pharmacokinetic and metabolic profiles of drugs, potentially offering several advantages.
- Used as a tracer or internal standard for quantitative analysis.
- Extends in vivo half-life and improves oral bioavailability.
- Improves metabolic characteristics and drug safety.
- Preserves therapeutic properties.
- Inhibits RSV replication in A549 cells.
- Shows strong antiviral activity against RSV in mice.
- Exhibits favorable pharmacokinetic properties and good safety profile.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.